Yang, X., Ma, X., Zhao, T., Croucher, D. R., Nguyen, E. V., Clark, K. C., . . . Daly, R. J. (2025). Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer. Nature communications, 16(1), 1871-19. https://doi.org/10.1038/s41467-025-57046-8
Chicago-Zitierstil (17. Ausg.)Yang, Xue, et al. "Activation of CAMK2 by Pseudokinase PEAK1 Represents a Targetable Pathway in Triple Negative Breast Cancer." Nature Communications 16, no. 1 (2025): 1871-19. https://doi.org/10.1038/s41467-025-57046-8.
MLA-Zitierstil (9. Ausg.)Yang, Xue, et al. "Activation of CAMK2 by Pseudokinase PEAK1 Represents a Targetable Pathway in Triple Negative Breast Cancer." Nature Communications, vol. 16, no. 1, 2025, pp. 1871-19, https://doi.org/10.1038/s41467-025-57046-8.